Shuwei Wu

Jiangsu Key Laboratory Of Neuropsychiatric Diseases And College Of Pharmaceutical Sciences
Suzhou, 215123, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors.

Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors.

Journal: European journal of medicinal chemistry

Published: May 10, 2023

Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease.

Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease.

Journal: Biochemical pharmacology

Published: April 13, 2023

Inhibition of lysosome-tethered Ragulator-Rag-3D complex restricts the replication of Enterovirus 71 and Coxsackie A16.

Inhibition of lysosome-tethered Ragulator-Rag-3D complex restricts the replication of Enterovirus 71 and Coxsackie A16.

Journal: The Journal of cell biology

Published: March 28, 2023

Design, synthesis, evaluation and optimization of potent IRAK4 inhibitors alleviating production of inflammatory cytokines in LPS-induced SIRS model.

Design, synthesis, evaluation and optimization of potent IRAK4 inhibitors alleviating production of inflammatory cytokines in LPS-induced SIRS model.

Journal: Bioorganic chemistry

Published: March 07, 2023

Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors.

Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: July 10, 2022

Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity.

Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity.

Journal: Bioorganic chemistry

Published: April 24, 2022

Synthesis and characterization of potent RIPK3 inhibitors based on a tricyclic scaffold.

Synthesis and characterization of potent RIPK3 inhibitors based on a tricyclic scaffold.

Journal: Future medicinal chemistry

Published: February 15, 2022

Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.

Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.

Journal: European journal of medicinal chemistry

Published: September 30, 2021

Ring closure strategy leads to potent RIPK3 inhibitors.

Ring closure strategy leads to potent RIPK3 inhibitors.

Journal: European journal of medicinal chemistry

Published: November 06, 2020

Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury.

Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury.

Journal: Frontiers in cell and developmental biology

Published: September 14, 2020

Design, Synthesis, and Characterization of Novel CXCR4 Antagonists Featuring Cyclic Amines.

Design, Synthesis, and Characterization of Novel CXCR4 Antagonists Featuring Cyclic Amines.

Journal: ChemMedChem

Published: April 24, 2020

Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity.

Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity.

Journal: European journal of medicinal chemistry

Published: April 07, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026